Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Experts to highlight inequity in accessing veterinary medicines
Professor Paulo Steagall.

Professor Paulo Steagall will lead the discussion at WSAVA World Congress.

The inequity in access to veterinary medicines faced by vets in Latin America and other countries is to go under the spotlight at the 2022 WSAVA World Congress.

Many vets struggle to access opioid analgesics to treat pain, leading to the unnecessary suffering of millions of companion animals. 

During the Congress, Professor Paulo Steagall, co-chair of the WSAVA's Therapeutics Guidelines Group (TGG), will lead a session entitled 'Shaping the Future', which will explore both the causes and consequences of accessing vital medicines.

The session will also see speakers from different parts of the world and TGG members talk about potential solutions in a panel discussion.

It follows the launch of the TGG's first List of Essential Medicines for Cats and Dogs in 2020 – a peer-reviewed list of core and complementary essential medicines designed to support the availability of drugs to perform the minimum standards of care. During his talk, Professor Steagall will call for suggestions, comments and revisions of the current list as part of an 'open audit', before it gets updated in 2023.

Professor Steagall said: “In addition to the welfare issues caused by the problems many colleagues experience in obtaining access to veterinary medicines, we should also consider the frustration this causes them as individuals as they are unable to provide the standard of veterinary care they have been trained to deliver. For a profession already under strain, this is just one more burden.

“We are delighted to be putting this issue in the global spotlight during this year’s WSAVA World Congress and hope that our discussions will help to create practical solutions, supporting pharmacovigilance and helping to mitigate the effects of a growing market for counterfeit pharmaceutical products.”

The WSAVA World Congress takes place in Lima, Peru, in October (29-31) and promises a packed scientific programme or cutting-edge thinking and new trends in companion animal care. For more information, visit wsava.org

Image (C) WSAVA.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.